Unichem gets USFDA nod for hypertension treatment tablets
NEW DELHI: Drug firm Unichem Laboratories has received approval from the US health regulator for its Losartan Potassium tablets used in treatment of hypertension.
"The company has received ANDA approval from the United States Food and Drug Administration (US FDA) for Losartan Potassium tablets USP," Unichem Laboratories said in a filing to BSE.
The product will be commercialised from the company's Ghaziabad plant, it added.
The product is generic version of Merck Sharp & Dohme Corp's Cozaar tablets in the strength of 25 mg, 50 mg and 100 mg, Unichem said.
Losartan Potassium is used for treatment of hypertension, it added.
"The company has received ANDA approval from the United States Food and Drug Administration (US FDA) for Losartan Potassium tablets USP," Unichem Laboratories said in a filing to BSE.
The product will be commercialised from the company's Ghaziabad plant, it added.
The product is generic version of Merck Sharp & Dohme Corp's Cozaar tablets in the strength of 25 mg, 50 mg and 100 mg, Unichem said.
Losartan Potassium is used for treatment of hypertension, it added.
Next Story
